BiomX Inc. (PHGE)
| Market Cap | 7.31M -48.9% |
| Revenue (ttm) | n/a |
| Net Income | -47.77M |
| EPS | -24.15 |
| Shares Out | 10.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 420,073 |
| Open | 0.8084 |
| Previous Close | 0.8386 |
| Day's Range | 0.7050 - 0.8100 |
| 52-Week Range | 0.3608 - 14.7120 |
| Beta | 1.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 20, 2026 |
About PHGE
BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company’s phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matche... [Read more]
Financial Performance
Financial StatementsNews
BiomX appoints Gabby Sarusi as strategic advisor
BiomX (PHGE) announced the appointment of Prof. Gabby Sarusi as Strategic Advisor to the Company. Prof. Sarusi will advise BiomX as the Company as the company expands its presence in…
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security Defense-industry veteran brings experience developing ima...
Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence
The company introduces an expanded on-premise and hybrid C5ISR suite that enables local AI processing, command automation, and response coordination for defense, security, and critical infrastructure ...
BiomX names Roy Timor-Rousso as Chief Business Officer
BiomX (PHGE) announced the appointment of Roy Timor-Rousso as Chief Business Officer, adding senior business & operational leadership as the company continues building around defense, security, and fi...
BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations
Roy brings defense leadership, digital infrastructure, and large scale commercialization experience as BiomX advances its defense and security transition Roy brings defense leadership, digital infrast...
BiomX Quarterly report: Q1 2026
BiomX has published its Q1 2026 quarterly earnings report on May 20, 2026.
BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand
Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response Transforms fragmented communication into real-time, AI-driven coordination, assignment, and ...
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems
AI-driven command and control platform applied in real-world railway operations, supporting broader infrastructure and security use cases AI-driven command and control platform applied in real-world r...
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
Acquisition expands BiomX's defense portfolio with aligned capabilities designed to integrate across detection, analysis, and response, reinforcing its position in AI-enabled security systems Acquisit...
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments Targets $81B command-and-control and video analytics markets by ...
Biomx Inc trading halted, news pending
14:33 EDT Biomx (PHGE) Inc trading halted, news pending
Biomx Inc trading halted, news pending
09:31 EDT Biomx (PHGE) Inc trading halted, news pending
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System
The platform delivers ~99% accuracy in real-world deployments across defense and infrastructure; When closed, the transaction value is estimated at approximately $45 million The platform delivers ~99%...
BiomX Adds Former Mossad Deputy to Advisory Board
Dr. Ehud (Udi) Levi brings decades of intelligence experience as Company evaluates expansion into security, defense, and counter-UAS technologies Dr. Ehud (Udi) Levi brings decades of intelligence exp...
BiomX receives noncompliance notification from Nasdaq
BiomX (PHGE) announced that the company received a notice from the staff of NYSE American that the company was not in compliance with the NYSE American’s continued listing standards in…
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
Discloses “Going Concern” Explanatory Paragraph in Auditor's Report Discloses “Going Concern” Explanatory Paragraph in Auditor's Report
BiomX launches X Security & Defense subsidiary in Israel
BiomX (PHGE) announced the launch of X Security & Defense LTD., a new wholly-owned subsidiary. The company will finance its 2026 operations with over $3M from internal funds, including for…
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations
Initiative marks entry into Israel's rapidly growing autonomous AI defense, firefighting and first response activities Initiative marks entry into Israel's rapidly growing autonomous AI defense, firef...
BiomX Proxy statement: Proxy filing
BiomX filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
BiomX issues letter to shareholders
BiomX (PHGE) released the following letter from its Chief Executive Officer to stockholders. “Over the past several weeks, BiomX has taken decisive steps to reshape its leadership, priorities, and fin...
BiomX CEO Issues Letter to Stockholders
CEO Letter to Stockholders highlights the Company's strategic and financial reset designed to strengthen BiomX in the near term and unlock future growth opportunities DOVER, Del., March 19, 2026 /PRNe...
BiomX Transcript: EGM 2026
Shareholders approved the issuance of common stock underlying Series Y preferred stock and warrants, as well as the potential adjournment to solicit more proxies if needed. Both proposals passed with sufficient votes, and management invited post-meeting questions.
BiomX downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis downgraded BiomX (PHGE) to Neutral from Buy. BiomX has “had a rough time as of late,” says the analyst, who notes that both the CEO…
BiomX names Michael Oster as CEO, David Rokach as CFO
BiomX (PHGE) announced the appointment of Michael Oster as CEI and David Rokach as CFO. Currently, Oster serves as CEO and board member of Saffron Tech Ltd., an agritech company…